最初の世代のMsbA阻害剤の独特なアロステリックメカニズム
François A Thélot1,2, Wenyi Zhang3,4, KangKang Song5,6
1Department of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
Science (New York, N.Y.)
|September 23, 2021
まとめ
2つのATP結合カセット (ABC) トランスポーター阻害剤であるTBT1とG247は,異なるメカニズムによって MsbA トランスポーターを調節する. これらの発見は,ABCトランスポーターの薬理学と新しい治療法の開発に関する重要な洞察を提供します.
科学分野:
- 生物化学
- 構造生物学
- 薬理学について
背景:
- ATP結合カセット (ABC) トランスポーターは,基板輸送に関与する重要な膜タンパク質です.
- 小分子阻害剤がABCトランスポーターを調節する方法を理解することは 薬の開発に不可欠です
- MsbAトランスポーターは重要な標的ですが,その抑制メカニズムは十分に理解されていません.
研究 の 目的:
- 2つのMsbA阻害剤であるTBT1とG247の異なる作用メカニズムを解明する.
- TBT1とG247によるATP水解の微分抑制の構造的基礎を調査する.
- ABCトランスポーターモデュレータの薬理学に関する洞察を提供するためです.
主な方法:
- 単粒子の冷凍電子顕微鏡 (冷凍EM) で高解像度構造を決定する.
- ATPの水解とトランスポーター活動を評価する機能的測定法.
- 阻害剤の結合部位を特徴付けるための生化学分析
主要な成果:
- TBT1とG247は,MsbAトランスメブラン領域内の隣接しているが別々のポケットに結合する.
- TBT1結合は非対称で,核酸結合領域 (NBD) の距離が縮小した内側向きの形状を誘導する.
- G247結合は,NBD距離が増加した対称で,内側に広く開かれた状態を促進します.
結論:
- MsbAトランスポーターに対するTBT1とG247の阻害メカニズムが異なっていることが明らかになりました.
- これらの発見は,ABCトランスポーター阻害剤の複雑な薬理性を強調しています.
- 異なる構造的成果は,ABCトランスポーターを標的とした合理的な薬剤設計のための基盤を提供します.
さらに関連する動画
関連する概念動画
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
2.1K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.1K
01:08Allosteric Regulation
61.3K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
61.3K
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
714
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
714
01:17Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
2.3K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
2.3K
01:58Cooperative Allosteric Transitions
8.2K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
8.2K
01:19Allosteric Proteins-ATCase
6.0K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
6.0K